let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma
Open Access
- 8 May 2015
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 13 (1) , 1-8
Abstract
Renal cell carcinoma (RCC) is characterized by inherent resistance to chemotherapy. Earlier studies demonstrated that microRNAs (miRNAs) might be involved in the chemosensitivity of cancers. MicroRNA let-7, a putative tumor suppressor, is dysregulated in many cancers. Our study aims to investigate the exact role of let-7 in chemotherapy sensitivity of 5-fluorouracil (5-FU) in RCC. The clinical significance of let-7b and let-7c expression in surgically resected specimens was assessed by qRT-PCR. Cell proliferation assay and colony formation assay were used to assess the survival of 786-O cells treated with let-7b or let-7c combined with 5-FU. Western blot was used to detect the expression of Akt2 and caspase-7. Luciferase assay was used to detect the direct binding of let-7b and let-7c to the 3′-untranslated region (UTR) of Akt2. Expression of let-7b and let-7c was significantly decreased in 32 paired clear cell renal cell carcinoma tissue specimens and the dysregulation of let-7b was associated with pathological grade. Transfection of let-7b or let-7c combined with 5-FU inhibited proliferation and potentiated the antitumor efficacies of 5-FU at tolerated concentration. let-7b and let-7c suppressed the luciferase activity of reporter plasmid containing the 3′-UTR of Akt2. Overexpression of let-7b and let-7c reduced Akt2 expression, and Akt2 inhibition enhanced the sensitivity to 5-FU by affecting apoptotic pathway. Expression of let-7b and let-7c was frequently decreased in clear cell renal cell carcinoma tissues. The dysregulation of let-7b and let-7c may be involved in chemoresistance of RCC cells to 5-FU by down-regulating Akt2.Keywords
This publication has 28 references indexed in Scilit:
- microRNA expression profiling of the developing mouse heartInternational Journal of Molecular Medicine, 2012
- Let‐7 modulates acquired resistance of ovarian cancer to TaxanesviaIMP‐1‐mediated stabilization of multidrug resistance 1International Journal of Cancer, 2011
- EAU Guidelines on Renal Cell Carcinoma: The 2010 UpdateEuropean Urology, 2010
- Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinomaBMC Urology, 2009
- Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancerCellular Signalling, 2009
- Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel-induced apoptosis via inhibition of the p38 pathwayApoptosis, 2007
- Twist Transcriptionally Up-regulates AKT2 in Breast Cancer Cells Leading to Increased Migration, Invasion, and Resistance to PaclitaxelCancer Research, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Elevated Akt Activation and Its Impact on Clinicopathological Features of Renal Cell CarcinomaJournal of Urology, 2003
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999